Dopamine Uptake Inhibitors [MoA]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Dopamine Uptake Inhibitors [MoA] includes 3 drugs with a combined 38,004 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
38,004
Combined Reports
All Dopamine Uptake Inhibitors [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| BUPROPION | Bupropion Hydrochloride (XL) | 35,634 | 8,577 | 10,246 | 24.1% |
| SOLRIAMFETOL | SUNOSI | 2,135 | 9 | 75 | 0.4% |
| BUPROPION HYDROBROMIDE | Aplenzin | 235 | 23 | 62 | 9.8% |
Common Side Effects in Dopamine Uptake Inhibitors [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Completed suicide | 5,095 | 5,078 |
| Drug ineffective | 4,467 | 165 |
| Toxicity to various agents | 3,837 | 2,577 |
| Headache | 2,589 | 128 |
| Depression | 2,579 | 173 |
| Overdose | 2,375 | 593 |
| Anxiety | 2,354 | 27 |
| Intentional overdose | 2,103 | 438 |
| Drug hypersensitivity | 2,009 | 117 |
| Seizure | 1,894 | 231 |